REQUEST A DEMO
Total
USD $0.00
Search more companies

Osvah Pharmaceutical Company Public Joint Stock (أسواه للدواء المساهمة العامة) (Iran)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Osvah Pharmaceutical Company Public Joint Stock Profile Updated: December 11, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Osvah Pharmaceutical Company Public Joint Stock (أسواه للدواء المساهمة العامة) is an enterprise based in Iran. Its main office is in Tehran. It operates in the Pharmaceutical Preparation Manufacturing sector. It was first established on April 04, 1966. It currently has a total number of 322 (2024) employees. In its most recent financial highlights, the company reported a net sales revenue increase of 15.64% in Q3C2025. Its’ total assets recorded a negative growth of 6.51%.

Headquarters
4 Km Of The Karaj Old Road, Cross Road Pasteurized Sheer, 17 Shahrivar St., Shad Abad - No.43, Po:Box 13185-1554
Tehran; Tehran; Postal Code: 13718-45311

Contact Details: Purchase the Osvah Pharmaceutical Company Public Joint Stock (أسواه للدواء المساهمة العامة) report to view the information.

Website: http://www.osvahpharma.com

Basic Information
Total Employees:
Purchase the Osvah Pharmaceutical Company Public Joint Stock (أسواه للدواء المساهمة العامة) report to view the information.
Outstanding Shares:
Purchase the Osvah Pharmaceutical Company Public Joint Stock (أسواه للدواء المساهمة العامة) report to view the information.
Financial Auditors:
Purchase the Osvah Pharmaceutical Company Public Joint Stock (أسواه للدواء المساهمة العامة) report to view the information.
Incorporation Date:
April 04, 1966
Key Executives
Purchase this report to view the information.
Chairperson
Purchase this report to view the information.
Vice Chairperson
Purchase this report to view the information.
Director / Member of the Management Board
Purchase this report to view the information.
Director / Member of the Management Board
Purchase this report to view the information.
Chief Executive Officer
Ownership Details
Purchase this report to view the information.
66.54%
Purchase this report to view the information.
18%
Purchase this report to view the information.
6%
Purchase this report to view the information.
1%
Subsidiaries
Daana Phrma Company Public Joint Stock
3%
Jaber Ebne Hayyan Pharmaceutical Company Public Joint Stock
0.12%
Company Performance
Financial values in the chart are available after Osvah Pharmaceutical Company Public Joint Stock (أسواه للدواء المساهمة العامة) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency IRR. Absolute financial data is included in the purchased report.
Net sales revenue
15.64%
Total Operating Revenue
15.56%
Operating Profit
364.06%
EBITDA
3198.91%
Net Profit/Loss for the Period
N/A
Total Assets
-6.51%
Total Equity
47.61%
Operating Profit Margin
22.68%
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Debt / Equity
-59619%
Quick Ratio
515.35%
Cash Ratio
0%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?